Brentwood, Tenn.-based HealthTrust has selected Farmers Branch, Texas-based Techway Services to provide IT asset recovery and recycling services for HealthTrust member facilities, according to a Techway Services news release.
Supply Chain
Cleveland-based CHAMPS Healthcare's Group Purchasing division has entered a three-year contract-pricing agreement with Mundelein, Ill.-based Medline offering CHAMPS members savings on custom procedure trays and sterile packs, according to a CHAMPS news release.
An affiliate of San Francisco-based Thoma Bravo, a private equity investment firm, has acquired Louisville, Colo.-based Global Healthcare Exchange, a private healthcare supply chain provider, for an undisclosed amount.
The National Institutes of Health has joined forces with 10 biopharmaceutical companies and seven nonprofit organizations to create the Accelerated Medicines Partnership, a five-year, $230 million joint initiative geared toward producing drugs more quickly.
An organization focused on green practices and sustainability at healthcare organizations has developed guidance to help hospitals better manage their supply chain.
Advertisement
The U.S. Food and Drug Administration has cleared Yoqneam, Israel-based Given Imaging's PillCam COLON for use for patients after an incomplete optical colonoscopy, according to a Given Imaging news release.
The first post-approval Nanostim leadless pacemaker, the first leadless pacemaker in the world, was implanted in a patient in Spain, according to a news release from St. Paul, Minn.-based St. Jude Medical, the manufacturer of the pacemaker.
Mundelein, Ill.-based Medline has acquired Temecula, Calif.-based Professional Hospital Supply and all of PHS' related facilities, according to a news release.
Winter is upon us, yet too often cold weather scenario planning is an afterthought for supply chain managers. But blizzards and ice storms are relatively common occurrences with a number of solutions to overcome challenges. Recent arctic blasts serve as…
A Research and Markets report projects the global infection control market to be worth $14 billion in 2017, increasing by 33 percent from 2012.